Aims and Scope of International Journal of Hematology
International Journal of Hematology is the official journal of the Japanese Society of Hematology. Since 2008, it has been published by Springer Japan, but used to be published by Carden Jennings.
Key Metrics
CiteScore 

3.9
Impact Factor 

< 5
SJR 

Q2Hematology

SNIP 

0.89
Recommended pre-submission checks
Powered by 

Topics Covered on International Journal of Hematology
International Journal of Hematology Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | SPRINGER JAPAN KK |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1991 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in International Journal of Hematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in International Journal of Hematology
Effectiveness and tolerability of switching from 20% subcutaneous immunoglobulin to hyaluronidase-facilitated subcutaneous immunoglobulin 10% in the same patients with secondary hypogammaglobulinemia.
- 20 May 2026
- International journal of hematology
Darbepoetin alfa for the treatment of anemia in myelodysplastic syndromes: a post-marketing surveillance study in Japan.
- 18 May 2026
- International journal of hematology
Daratumumab-based therapy in systemic AL amyloidosis including advanced cardiac involvement: a single center study.
- 18 May 2026
- International journal of hematology
Letter comments on: "Measurable residual disease after venetoclax treatment for relapsed or refractory chronic lymphocytic leukemia in Japan".
- 13 May 2026
- International journal of hematology
T-cell fitness, metabolic tumor volume, and serum LDH levels are associated with response to axicabtagene ciloleucel.
- 12 May 2026
- International journal of hematology
Personalized multivariable clinical prognostic model for patients with acute myeloid leukemia receiving intensive chemotherapy.
- 12 May 2026
- International journal of hematology
Effectiveness and tolerability of switching from 20% subcutaneous immunoglobulin to hyaluronidase-facilitated subcutaneous immunoglobulin 10% in the same patients with secondary hypogammaglobulinemia.
- 20 May 2026
- International journal of hematology
Darbepoetin alfa for the treatment of anemia in myelodysplastic syndromes: a post-marketing surveillance study in Japan.
- 18 May 2026
- International journal of hematology
Daratumumab-based therapy in systemic AL amyloidosis including advanced cardiac involvement: a single center study.
- 18 May 2026
- International journal of hematology
Letter comments on: "Measurable residual disease after venetoclax treatment for relapsed or refractory chronic lymphocytic leukemia in Japan".
- 13 May 2026
- International journal of hematology
T-cell fitness, metabolic tumor volume, and serum LDH levels are associated with response to axicabtagene ciloleucel.
- 12 May 2026
- International journal of hematology
Personalized multivariable clinical prognostic model for patients with acute myeloid leukemia receiving intensive chemotherapy.
- 12 May 2026
- International journal of hematology